184 related articles for article (PubMed ID: 14582135)
1. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).
Monaghan SA; Peterson LC; James C; Marszalek L; Khoong A; Bachta DJ; Karpus WJ; Goolsby CL
Cytometry B Clin Cytom; 2003 Nov; 56(1):30-42. PubMed ID: 14582135
[TBL] [Abstract][Full Text] [Related]
2. A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.
Li Y; Tong X; Huang L; Li L; Wang C; He C; Liu S; Wang Z; Xiao M; Mao X; Zhang D
Cancer Med; 2021 Jul; 10(13):4387-4396. PubMed ID: 34061467
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotype does not correlate with lymph node histology in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Asplund SL; McKenna RW; Howard MS; Kroft SH
Am J Surg Pathol; 2002 May; 26(5):624-9. PubMed ID: 11979092
[TBL] [Abstract][Full Text] [Related]
4. Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases.
Kroft SH; Dawson DB; McKenna RW
Am J Clin Pathol; 2001 Mar; 115(3):385-95. PubMed ID: 11242795
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance of CD20 and FMC7 expression in B-cell disorders.
Delgado J; Matutes E; Morilla AM; Morilla RM; Owusu-Ankomah KA; Rafiq-Mohammed F; del Giudice I; Catovsky D
Am J Clin Pathol; 2003 Nov; 120(5):754-9. PubMed ID: 14608903
[TBL] [Abstract][Full Text] [Related]
6. CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection.
Garcia Vela J; Delgado I; Benito L; Monteserin M; Garcia Alonso L; Somolinos N; Andreu M; Oña F
Leukemia; 1999 Oct; 13(10):1501-5. PubMed ID: 10516749
[TBL] [Abstract][Full Text] [Related]
7. Utilization of a scoring system for diagnosis of chronic lymphocytic leukemia in Thai patients.
Promsuwicha O; Songmuang W; Auewarakul CU
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S232-8. PubMed ID: 21721452
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders.
McCarron KF; Hammel JP; Hsi ED
Am J Clin Pathol; 2000 Jun; 113(6):805-13. PubMed ID: 10874881
[TBL] [Abstract][Full Text] [Related]
9. The role of immunophenotyping in differential diagnosis of chronic lymphocytic leukemia.
Ivancević TD; Kurtović NK; Knezević V; Bogdanović A; Mihaljević B; Bozić B; Gotić M
Srp Arh Celok Lek; 2014; 142(3-4):197-203. PubMed ID: 24839775
[TBL] [Abstract][Full Text] [Related]
10. Morphologically typical and atypical B-cell chronic lymphocytic leukemias display a different pattern of surface antigenic density.
D'Arena G; Dell'Olio M; Musto P; Cascavilla N; Perla G; Savino L; Greco MM
Leuk Lymphoma; 2001 Aug; 42(4):649-54. PubMed ID: 11697493
[TBL] [Abstract][Full Text] [Related]
11. Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody.
Huh YO; Pugh WC; Kantarjian HM; Stass SA; Cork A; Trujillo JM; Keating MJ
Am J Clin Pathol; 1994 Mar; 101(3):283-9. PubMed ID: 8135183
[TBL] [Abstract][Full Text] [Related]
12. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).
Moreau EJ; Matutes E; A'Hern RP; Morilla AM; Morilla RM; Owusu-Ankomah KA; Seon BK; Catovsky D
Am J Clin Pathol; 1997 Oct; 108(4):378-82. PubMed ID: 9322589
[TBL] [Abstract][Full Text] [Related]
13. Clinical Flow-Cytometric Testing in Chronic Lymphocytic Leukemia.
Salem DA; Stetler-Stevenson M
Methods Mol Biol; 2019; 2032():311-321. PubMed ID: 31522426
[TBL] [Abstract][Full Text] [Related]
14. CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype.
Schlette E; Medeiros LJ; Keating M; Lai R
Arch Pathol Lab Med; 2003 May; 127(5):561-6. PubMed ID: 12708898
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
[TBL] [Abstract][Full Text] [Related]
17. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia.
Geisler CH; Larsen JK; Hansen NE; Hansen MM; Christensen BE; Lund B; Nielsen H; Plesner T; Thorling K; Andersen E
Blood; 1991 Oct; 78(7):1795-802. PubMed ID: 1717071
[TBL] [Abstract][Full Text] [Related]
18. FMC7 antigen expression on normal and malignant B-cells can be predicted by expression of CD20.
Hübl W; Iturraspe J; Braylan RC
Cytometry; 1998 Apr; 34(2):71-4. PubMed ID: 9579603
[TBL] [Abstract][Full Text] [Related]
19. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
